BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 2834931)

  • 61. [Drug resistance of Plasmodium falciparum in the Congo. 2. Comparative study in vivo of chloroquine and amodiaquine in Brazzaville schoolchildren (November 1986)].
    Carme B; Mbitsi A; Moudzeo H; Ndinga M; Eozenou P
    Bull Soc Pathol Exot Filiales; 1987; 80(3 Pt 2):426-33. PubMed ID: 3319250
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evaluation of amodiaquine treatment of chloroquine-resistant Plasmodium falciparum malaria on Zanzibar, 1982.
    Campbell CC; Payne D; Schwartz IK; Khatib OJ
    Am J Trop Med Hyg; 1983 Nov; 32(6):1216-20. PubMed ID: 6359904
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Sensitivity of Plasmodium falciparum to mefloquine-sulphadoxine-pyrimethamine (Fansimef) in vivo and to mefloquine alone in vitro in Nigeria.
    Salako LA; Aderounmu AF; Laoye JO; Makinde JM; Adio RA
    Ann Trop Med Parasitol; 1988 Aug; 82(4):325-30. PubMed ID: 3075441
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A comparison of the in vitro activities of amodiaquine and desethylamodiaquine against isolates of Plasmodium falciparum.
    Childs GE; Boudreau EF; Milhous WK; Wimonwattratee T; Pooyindee N; Pang L; Davidson DE
    Am J Trop Med Hyg; 1989 Jan; 40(1):7-11. PubMed ID: 2644858
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Susceptibility of Plasmodium falciparum to chloroquine and mefloquine in Somalia.
    Warsame M; Lebbad M; Ali S; Wernsdorfer WH; Björkman A
    Trans R Soc Trop Med Hyg; 1988; 82(2):202-4. PubMed ID: 3055452
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A phase-III clinical trial of mefloquine in children with chloroquine-resistant falciparum malaria in Thailand.
    Chongsuphajaisiddhi T; Sabchareon A; Chantavanich P; Singhasivanon V; Attanath P; Wernsdorfer WH; Sheth UK
    Bull World Health Organ; 1987; 65(2):223-6. PubMed ID: 3301042
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Ex-vivo Sensitivity of Plasmodium falciparum to Common Anti-malarial Drugs: The Case of Kéniéroba, a Malaria Endemic Village in Mali.
    Traoré K; Diakité SAS; Bah S; Konaté DS; Dabitao D; Sanogo I; Sangaré M; Dama S; Keita B; Doumbouya M; Guindo MA; Doumbia S; Diakité M
    Drugs R D; 2020 Sep; 20(3):249-255. PubMed ID: 32557086
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Drug sensitivity of malaria in a population of children in Pointe-Noire, Congo, in the first half of 1986].
    Simon F; Porte J; Verdier F; Guigon D; Drouville C; Le Bras J
    Bull Soc Pathol Exot Filiales; 1987; 80(3 Pt 2):417-25. PubMed ID: 3319249
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Plasmodium falciparum: mefloquine resistance produced in vitro.
    Lambros C; Notsch JD
    Bull World Health Organ; 1984; 62(3):433-8. PubMed ID: 6380785
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The in vitro response of Plasmodium falciparum to amodiaquine, quinine and quinidine in Tanga region, Tanzania.
    Kilimali VA
    East Afr Med J; 1990 May; 67(5):336-40. PubMed ID: 2202587
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Comparative efficacy of chloroquine and amodiaquine (25 and 35 mg/kg) in school children infected with P. falciparum (Brazzaville, March 1990)].
    Carme B; Sathounkasi C; Mbitsi A; Ndounga M; Gay F; Chandenier J; Schmitt JL; Samba G
    Bull Soc Pathol Exot; 1991; 84(1):77-9. PubMed ID: 2065405
    [TBL] [Abstract][Full Text] [Related]  

  • 72. In vitro response of chloroquine-resistant Plasmodium falciparum to mefloquine.
    López Antuñano FJ; Wernsdorfer WH
    Bull World Health Organ; 1979; 57(4):663-5. PubMed ID: 393426
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Micro in vitro assessment of Plasmodium falciparum sensitivity to chloroquine and mefloquine in Gujarat.
    Karmakar P; Dutt SC; Narasimham MV; Sharma RC
    Indian J Malariol; 1990 Mar; 27(1):37-42. PubMed ID: 2200725
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical efficacy of mefloquine in children suffering from chloroquine-resistant Plasmodium falciparum malaria in Nigeria.
    Sowunmi A; Salako LA; Walker O; Ogundahunsi OA
    Trans R Soc Trop Med Hyg; 1990; 84(6):761-4. PubMed ID: 2096499
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A double-blind comparative clinical trial of mefloquine and chloroquine in symptomatic falciparum malaria.
    Kofi Ekue JM; Ulrich AM; Rwabwogo-Atenyi J; Sheth UK
    Bull World Health Organ; 1983; 61(4):713-8. PubMed ID: 6354507
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Uncomplicated attack of malaria in an area with high resistance to chloroquine. I. Evaluation of a short treatment with quinine].
    Jambou R; Abissegue B; Gelas H; Ghipponi PM; Farinotti R; Le Bras J; Hengy C
    Bull Soc Pathol Exot; 1990; 83(1):46-52. PubMed ID: 2190704
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Chloroquine resistant malaria in West Malaysia.
    Sandosham AA; Fredericks HJ; Ponnampalam JT; Seow CL; Ismail O; Othman AM; Ali AR
    J Trop Med Hyg; 1975 Mar; 78(3):54-8. PubMed ID: 1095776
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Decrease in susceptibility of Plasmodium falciparum to mefloquine in continuous culture.
    Brockelman CR; Monkolkeha S; Tanariya P
    Bull World Health Organ; 1981; 59(2):249-52. PubMed ID: 7018728
    [TBL] [Abstract][Full Text] [Related]  

  • 79. New trends in chloroquine efficacy in the treatment of malaria: significance of low (scanty) parasitaemia in an endemic area, with emerging chloroquine-resistant P. falciparum.
    Ezedinachi E; Alaribe AA; Meremikwu M; Ejezie GC
    Cent Afr J Med; 1992 Jul; 38(7):303-7. PubMed ID: 1477881
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Proposals for a new therapeutic strategy for simple Plasmodium falciparum malaria attacks in Cameroon.
    Louis JP; Hengy C; Louis FJ; Gazin P; Jambou R; Gardon J; Fadat G; Trebucq A
    Trop Med Parasitol; 1992 Jun; 43(2):118-20. PubMed ID: 1519023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.